The China Mail - Decade since Ebola, Sierra Leone fights another deadly fever

USD -
AED 3.673042
AFN 65.000368
ALL 81.503989
AMD 360.340403
ANG 1.789785
AOA 918.000367
ARS 1544.046724
AUD 1.454757
AWG 1.8
AZN 1.70397
BAM 1.75029
BBD 2.013844
BDT 124.537437
BGN 1.747831
BHD 0.37735
BIF 3010
BMD 1
BND 1.281347
BOB 11.99429
BRL 5.504904
BSD 0.999897
BTN 93.858629
BWP 13.774679
BYN 2.994523
BYR 19600
BZD 2.011053
CAD 1.41135
CDF 2320.000362
CHF 0.820469
CLF 0.02484
CLP 977.630396
CNY 6.676504
CNH 6.67282
COP 3251.53
CRC 453.465426
CUC 1
CUP 23.998962
CVE 99.403894
CZK 21.83445
DJF 177.720393
DKK 6.708504
DOP 60.750393
DZD 136.38704
EGP 53.769786
ERN 15
ETB 161.203874
EUR 0.896804
FJD 2.25525
FKP 0.7479
GBP 0.748671
GEL 2.59504
GGP 0.7479
GHS 11.68504
GIP 0.7479
GMD 74.503851
GNF 8857.503848
GTQ 7.64085
GYD 209.627114
HKD 7.84215
HNL 27.07504
HRK 6.76901
HTG 131.052321
HUF 326.000354
IDR 18108.5
ILS 3.18593
IMP 0.7479
INR 94.04725
IQD 1514
IRR 1891353.000352
ISK 122.790386
JEP 0.7479
JMD 158.687685
JOD 0.70904
JPY 158.50504
KES 129.950385
KGS 87.447804
KHR 4080.00035
KMF 442.00035
KPW 899.999961
KRW 1363.803789
KWD 0.31098
KYD 0.833408
KZT 448.201333
LAK 22505.000349
LBP 89550.000349
LKR 332.502562
LRD 170.303772
LSL 16.560381
LTL 2.95274
LVL 0.60489
LYD 6.430381
MAD 9.757504
MDL 17.8737
MGA 4595.000347
MKD 55.203803
MMK 2099.697346
MNT 3600.739032
MOP 8.072028
MRU 40.250379
MUR 47.030378
MVR 15.403739
MWK 1737.000345
MXN 18.62534
MYR 4.061504
MZN 63.903729
NAD 16.560377
NGN 1347.210377
NIO 36.610377
NOK 9.459904
NPR 150.173627
NZD 1.803102
OMR 0.384144
PAB 0.999964
PEN 3.442504
PGK 4.492039
PHP 63.108038
PKR 276.625038
PLN 3.94555
PYG 6249.384815
QAR 3.643038
RON 4.792204
RSD 105.586038
RUB 81.925564
RWF 1475
SAR 3.754695
SBD 8.048583
SCR 14.018084
SDG 601.503676
SEK 9.894504
SGD 1.282604
SHP 0.748923
SLE 22.950371
SLL 20969.504398
SOS 571.503662
SRD 37.583504
STD 20697.981008
STN 22.275
SVC 8.748764
SYP 13001.999685
SZL 16.560369
THB 33.550369
TJS 9.224126
TMT 3.5
TND 2.985504
TOP 2.40776
TRY 50.141304
TTD 6.780829
TWD 32.775304
TZS 2642.503628
UAH 45.297
UGX 4089.81484
UYU 40.226773
UZS 12000.000334
VES 896.316404
VND 25582.5
VUV 119.504303
WST 2.787821
XAF 588.264929
XAG 0.019249
XAU 0.00024594347
XCD 2.70255
XCG 1.801976
XDR 0.707052
XOF 588.264929
XPF 107.450363
YER 236.625037
ZAR 16.51847
ZMK 9001.203584
ZMW 20.318702
ZWL 321.999592
SSP 5745.505339
MXV 2.095424
  • RYCEF

    0.4000

    19.71

    +2.03%

  • CMSC

    0.0000

    20.4

    0%

  • BTI

    0.4200

    56.05

    +0.75%

  • BP

    0.2800

    44.43

    +0.63%

  • RBGPF

    1.6000

    67

    +2.39%

  • RIO

    -0.1500

    94.41

    -0.16%

  • AZN

    -0.4300

    166.15

    -0.26%

  • GSK

    0.4600

    49.7

    +0.93%

  • BCE

    -0.4100

    20.56

    -1.99%

  • NGG

    -0.2500

    75.24

    -0.33%

  • VOD

    -0.0400

    16.58

    -0.24%

  • RELX

    -0.4500

    33.07

    -1.36%

  • BCC

    -0.5500

    76.59

    -0.72%

  • CMSD

    -0.0300

    20.27

    -0.15%

  • JRI

    -0.2500

    10.77

    -2.32%

Decade since Ebola, Sierra Leone fights another deadly fever
Decade since Ebola, Sierra Leone fights another deadly fever / Photo: © AFP

Decade since Ebola, Sierra Leone fights another deadly fever

Rummaging in the darkness of a tiny mud and thatch home in eastern Sierra Leone, ecologist James Koninga plucks a metal rat trap from under a collapsed bedframe.

Text size:

The 62-year-old belongs to a group of researchers tracking the deadly Lassa fever, a viral haemorrhagic illness endemic in several West African countries and transmitted by infected rats.

Koninga knows all too well what is at stake -- he spent a gruelling 20 days in hospital with a Lassa-induced fever, headache and diarrhoea as a young researcher 30 years ago.

"I thought I was going away, I was going to die," he said.

Ten years ago, the haemorrhagic Ebola virus devastated this region, killing over 11,000 people across Guinea, Sierra Leone and Liberia.

Sierra Leone has not recorded an Ebola case since the outbreak ended in 2016, thanks partly to a vaccine rollout.

In Kenema district, an early Ebola epicentre, scientists are using the lessons learned a decade ago to try to stop Lassa fever in its tracks.

With an overall fatality rate of one percent, Lassa is nowhere near as deadly as Ebola, which kills on average 50 percent of sufferers, according to the World Health Organization.

But one in five Lassa infections can result in severe illness with a fatality rate of 15 percent.

While cases have largely plateaued in Sierra Leone, researchers are seeing a spread beyond traditional Lassa hotspots.

There is no licensed vaccine and only limited treatment, with the scars of Ebola preventing many from seeking early life-saving help.

- Living with rats -

Monitoring the rodent population is crucial in remote villages like Mapuma, where some 20 houses lie enveloped by dense forest.

"Rats burrow inside the houses for shelter," explained Koninga, donning a face shield and gloves.

Humans usually contract Lassa virus after having contact with the urine, saliva or droppings of infected rats.

"If people come in from the bush with cuts on them and lie on the bed, they could be infected."

Proximity to the forest, rudimentary mud construction, and uncovered grain and water storage make the dwellings "five-star hotels" for rats, said Lansana Kanneh, 58, field supervisor at the region's Kenema Government Hospital (KGH).

"Food is scarce for these people so sometimes they even eat the food that has been partially eaten by the rodent," he added.

Trappers can find up to 20 rats per day in some villages.

After identifying if the rodents are the Lassa-carrying Mastomys variety, samples are collected for analysis.

The rats then receive an injection that prevents viral transmission before being released.

Lassa virus infects between 100,000 and 300,000 people annually in West Africa, killing roughly 5,000, according to the Africa Centres for Disease Control and Prevention.

But the figures likely underestimate the true scale given surveillance challenges.

Admissions to the Lassa unit at KGH -- Sierra Leone's only dedicated treatment centre -– have declined in the past decade.

Patients normally arrive in the 14-bed isolation ward during the dry season from November to May, but this once-predictable pattern is increasingly uncertain.

- 'Lassa blood' -

"Now we see cases year-round," said Donald Grant, head of the KGH Lassa fever programme.

The team are also noticing Lassa beyond traditionally endemic zones, with Grant suspecting an improvement in testing as well as deforestation driving rodents into closer contact with humans.

Over the past decade, KGH has also seen an alarming uptick in Lassa patient mortality, which now stands at over 50 percent.

"We've seen a lot of these cases coming in in their late stages," said Kanneh.

"Sometimes they only spend 24 to 48 hours in the hospital, and they die."

Rapid detection is the key to survival, but non-specific febrile symptoms mean Lassa is commonly misdiagnosed as malaria, cholera or typhoid.

Hours-long journeys on dirt roads prevent many from seeking treatment.

As does the trauma from Ebola, which killed some 4,000 Sierra Leoneans.

"The community people thought that Ebola was brought by the health workers," Kanneh said, explaining that a lingering mistrust contributed to reduced admissions.

A KGH team raises awareness in local communities about seeking rapid help and ensuring good domestic hygiene.

It is a message well-received by Musa Mosoh, a 53-year-old Lassa survivor who lost seven family members to the illness.

As the morning rain fell in his village of Panguma -- a Lassa red zone -- Mosoh recalled how his family had faced stigma from the community.

"Now... people have got the understanding we are not from Lassa blood, it's just a sickness."

Mosoh tells those with a continuous fever or headache to go straight to the hospital, and even keeps cats to repel any virus-carrying rodents.

Grant, the doctor, is hopeful of a vaccine in the next few years.

Participants in Nigeria and Liberia are currently being given the first-ever Lassa vaccine to reach phase two trials -- the midway point of testing in humans.

But Grant still urges caution.

Ebola "taught us a lesson that we need not wait until that critical moment that it overwhelms all of us," he said.

"We need to act now."

M.Zhou--ThChM